Redoxis
- CMO, CRO
- Other R&D services
Redoxis is a Swedish preclinical CRO specializing in inflammation and autoimmune diseases. We offer customized in vitro and in vivo models for efficacy, mechanism-of-action, and product characterization studies—supporting early drug development across small molecules, biologics, cell and gene therapies, and mRNA platforms.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}